Although the viral defense mechanism that we describe is likely to be important for controlling asymptomatic and mildly symptomatic SARS-CoV-2 infections, endogenous overexpression of FXa during severe SARS-CoV-2 infection might contribute to complications of COVID-19, especially thrombotic events53,58,64. The gene discussed is F10; the disease is COVID-19.